Related Experiment Video
Updated: Aug 12, 2026

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
Innate host defense lysozyme may help control Staphylococcus aureus in atopic dermatitis
Patrick M Schlievert1, Samuel H Kilgore1, Evgeny Berdyshev2
1Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Atopic dermatitis patients may increase lysozyme production to control Staphylococcus aureus colonization. Lysozyme inhibits S. aureus toxins, potentially reducing inflammation and improving skin condition.
Area of Science:
- Immunology
- Dermatology
- Microbiology
Background:
- Atopic dermatitis (AD) is linked to Staphylococcus aureus colonization, which exacerbates symptoms.
- S. aureus produces toxins and enzymes contributing to AD persistence.
- Dupilumab treatment for AD reduces S. aureus colonization.
Purpose of the Study:
- Investigate the role of host lysozyme in controlling S. aureus burden in AD patients.
- Determine the relationship between lysozyme levels, S. aureus colonization, and AD severity.
- Explore the impact of dupilumab on lysozyme and S. aureus levels.
Main Methods:
- Correlational analysis of S. aureus abundance and lysozyme levels in AD patients.
- Observation of changes in S. aureus and lysozyme levels during dupilumab treatment and placebo phases.
- Assessment of lysozyme's effect on S. aureus exoprotein production in vitro.
Main Results:
- Reduced S. aureus abundance during dupilumab treatment correlated with lower lysozyme levels.
- S. aureus and lysozyme levels remained stable in placebo-treated participants.
- S. aureus and lysozyme levels decreased when placebo participants switched to dupilumab.
- Lysozyme inhibits S. aureus exoprotein production but does not kill the bacteria.
Conclusions:
- AD patients may upregulate lysozyme production in response to S. aureus colonization.
- Lysozyme plays a role in modulating S. aureus-induced inflammation in AD.
- Balancing S. aureus-driven inflammation with host innate immunity, like lysozyme, is crucial for AD management.
Related Concept Videos
Staphylococcal Skin Infections
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
The Skin Microbiota
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Clinical Significance of Antibiotic Resistance
